Several published works show an increase of IL-10 in critically ill COVID-19 patients despite its general anti-inflammatory nature, even proposing this protein as a prognostic biomarker (41, 42), together with other well-known inflammatory cytokines such as IL-6. This evidence concerns the gene IL10 and COVID-19.